Our findings are in agreement with another report that found that KLK6 mRNA expression is an independent, unfavorable molecular prognostic biomarker in colorectal adenocarcinoma, with an additional prognostic value in patients without regional or distant metastases [20]. This evidence concerns the gene KLK6 and colorectal adenocarcinoma.